DNA Script
DNA Script makes SYNTAX, the benchtop enzymatic DNA printer that lets research labs synthesize oligos in-house overnight.
- Company
- Le Kremlin-Bicêtre, FRFrance
DNA Script makes SYNTAX, the benchtop enzymatic DNA printer that lets research labs synthesize oligos in-house overnight.
dnascript.comCrawled Oct 24, 2026
DNA Script has developed and optimized a portfolio of proprietary synthesis enzymes engineered to perform de novo synthesis of nucleic acids with high fidelity and high coupling efficiency.
Introducing the SYNTAX nucleic acid production platform enabling same-day in-lab synthesis of custom oligos using enzymatic DNA synthesis technology.
Introducing the SYNTAX nucleic acid production platform enabling same-day synthesis of custom oligos using enzymatic DNA synthesis technology.
The application note compares the SYNTAX benchtop platform’s on-demand DNA oligo production to competitors’ methods.
The role involves joining DNA Script’s System Integration team to develop new DNA synthesis processes and instrumentation.
DNA Script develops enzymatic DNA synthesis technology, integrating innovations in enzymes, chemistries, and instrumentation to create SYNTAX, the first benchtop DNA printer.
DNA Script’s SYNTAX printer and enzymatic methods produce longer, complex DNA sequences for research applications.
DNA Script and a leading healthcare solutions provider receive up to **$26 million** from **ARPA-H** to advance **cell-free DNA bioproduction** for next-generation therapies. The **FLASH program**, in collaboration with **GE HealthCare**, aims to develop faster, distributed DNA manufacturing methods. This funding supports scalable production of therapeutic DNA sequences without traditional cell-based systems.
Aug 2026DNA ScriptNews article
DNA Script partners with Imperial Life Sciences (ILS) to distribute its SYNTAX platform across India. ILS will handle sales, technical support, and application expertise for researchers using the platform to produce high-quality single-stranded DNA (ssDNA) oligonucleotides. The agreement aims to improve access to faster and more flexible ssDNA solutions for local researchers.
Jul 2026Genomics Research from Technology NetworksNews article
DNA Script secures $200 million in its Series C funding round, completing the second tranche. The company, specializing in Enzymatic DNA Synthesis (EDS) for on-demand DNA printing, has now raised a total of $315 million since its founding in 2014. This latest infusion supports its growth in synthetic biology applications.
Jan 2022BioSpaceNews article
DNA Script secures $38.5 million in funding to accelerate commercialization of its DNA manufacturing process, which the company claims represents a major advancement in genetic material production. The technology aims to streamline and speed up the synthesis of DNA, potentially transforming industries reliant on genetic engineering. The funding will support scaling efforts for broader adoption.
May 2019TechCrunchNews article